{"id":688074,"date":"2022-09-22T09:05:08","date_gmt":"2022-09-22T13:05:08","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/artelo-biosciences-to-present-at-the-2022-ladenburg-thalmann-healthcare-conference-on-september-29th\/"},"modified":"2022-09-22T09:05:08","modified_gmt":"2022-09-22T13:05:08","slug":"artelo-biosciences-to-present-at-the-2022-ladenburg-thalmann-healthcare-conference-on-september-29th","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/artelo-biosciences-to-present-at-the-2022-ladenburg-thalmann-healthcare-conference-on-september-29th\/","title":{"rendered":"Artelo Biosciences to Present at the 2022 Ladenburg Thalmann Healthcare Conference on September 29th"},"content":{"rendered":"
\n

SOLANA BEACH, Calif., Sept. 22, 2022 (GLOBE NEWSWIRE) — Artelo Biosciences, Inc.<\/a>\u00a0(Nasdaq:\u00a0ARTL)<\/strong>,<\/strong> a clinical-stage pharmaceutical company focused on modulating lipid-signaling pathways to develop treatments for people living with cancer, pain, and neurological conditions, today announced that it will be presenting at the 2022 Ladenburg Thalmann Healthcare Conference being held on September 29, 2022 at the Sofitel Hotel in New York City.<\/p>\n

Gregory D. Gorgas, Chief Executive Officer of Artelo, is scheduled to present on Thursday, September 29th<\/sup> at 8:30 a.m. Eastern Time., with one-on-one meetings to be held throughout the conference. The webcast of the Company\u2019s presentation can also be accessed\u00a0here<\/a>\u00a0and on the investor relations section of Artelo’s website at\u00a0https:\/\/ir.artelobio.com\/<\/a> as of 7:00 a.m. Eastern Time on Friday, September 30, 2022.<\/p>\n

\n About Artelo Biosciences<\/strong><\/p>\n

Artelo Biosciences, Inc. is a clinical-stage pharmaceutical company focused on modulating lipid-signaling pathways to develop treatments for people living with cancer, pain, and neurological conditions. Artelo is advancing a portfolio of broadly applicable product candidates designed to address significant unmet needs in multiple diseases and conditions, including anorexia, cancer, PTSD, pain, and inflammation. Led by proven pharmaceutical executives collaborating with highly respected researchers and technology experts, Artelo applies leading edge scientific, regulatory, and commercial discipline to develop high-impact therapies. More information is available at\u00a0www.artelobio.com<\/a>\u00a0and Twitter:\u00a0@ArteloBio<\/a>.<\/p>\n

\n Forward Looking Statements<\/strong>\n <\/p>\n

\n This press release contains certain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934 and Private Securities Litigation Reform Act, as amended, including those relating to Artelo\u2019s product development, clinical and regulatory timelines, market opportunity, competitive position, possible or assumed future results of operations, business strategies, potential growth opportunities and other statement that are predictive in nature. These forward-looking statements are based on current expectations, estimates, forecasts and projections about the industry and markets in which we operate and management\u2019s current beliefs and assumptions. These statements may be identified by the use of forward-looking expressions, including, but not limited to, \u201cexpect,\u201d \u201canticipate,\u201d \u201cintend,\u201d \u201cplan,\u201d \u201cbelieve,\u201d \u201cestimate,\u201d \u201cpotential,\u201d \u201cpredict,\u201d \u201cproject,\u201d \u201cshould,\u201d \u201cwould\u201d and similar expressions and the negatives of those terms. These statements relate to future events or our financial performance and involve known and unknown risks, uncertainties, and other factors which may cause actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by the forward-looking statements. Such factors include those set forth in Artelo\u2019s filings with the Securities and Exchange Commission, including our ability to raise additional capital in the future. Prospective investors are cautioned not to place undue reliance on such forward-looking statements, which speak only as of the date of this press release. Artelo undertakes no obligation to publicly update any forward-looking statement, whether as a result of new information, future events or otherwise, except to the extent required by applicable securities laws.<\/em>\n <\/p>\n

\n Investor Relations Contact:<\/strong>
\n
Crescendo Communications, LLC
Tel: 212-671-1020
Email:\u00a0ARTL@crescendo-ir.com<\/a><\/p>\n


\n
\n \n <\/div>\n

<\/div>\n","protected":false},"excerpt":{"rendered":"

SOLANA BEACH, Calif., Sept. 22, 2022 (GLOBE NEWSWIRE) — Artelo Biosciences, Inc.\u00a0(Nasdaq:\u00a0ARTL), a clinical-stage pharmaceutical company focused on modulating lipid-signaling pathways to develop treatments for people living with cancer, pain, and neurological conditions, today announced that it will be presenting at the 2022 Ladenburg Thalmann Healthcare Conference being held on September 29, 2022 at the Sofitel Hotel in New York City. Gregory D. Gorgas, Chief Executive Officer of Artelo, is scheduled to present on Thursday, September 29th at 8:30 a.m. Eastern Time., with one-on-one meetings to be held throughout the conference. The webcast of the Company\u2019s presentation can also be accessed\u00a0here\u00a0and on the investor relations section of Artelo’s website at\u00a0https:\/\/ir.artelobio.com\/ as of 7:00 a.m. Eastern Time on Friday, September 30, … <\/p>\n

Continue reading “Artelo Biosciences to Present at the 2022 Ladenburg Thalmann Healthcare Conference on September 29th”<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-688074","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"\nArtelo Biosciences to Present at the 2022 Ladenburg Thalmann Healthcare Conference on September 29th - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/artelo-biosciences-to-present-at-the-2022-ladenburg-thalmann-healthcare-conference-on-september-29th\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Artelo Biosciences to Present at the 2022 Ladenburg Thalmann Healthcare Conference on September 29th - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"SOLANA BEACH, Calif., Sept. 22, 2022 (GLOBE NEWSWIRE) — Artelo Biosciences, Inc.\u00a0(Nasdaq:\u00a0ARTL), a clinical-stage pharmaceutical company focused on modulating lipid-signaling pathways to develop treatments for people living with cancer, pain, and neurological conditions, today announced that it will be presenting at the 2022 Ladenburg Thalmann Healthcare Conference being held on September 29, 2022 at the Sofitel Hotel in New York City. Gregory D. Gorgas, Chief Executive Officer of Artelo, is scheduled to present on Thursday, September 29th at 8:30 a.m. Eastern Time., with one-on-one meetings to be held throughout the conference. The webcast of the Company\u2019s presentation can also be accessed\u00a0here\u00a0and on the investor relations section of Artelo’s website at\u00a0https:\/\/ir.artelobio.com\/ as of 7:00 a.m. Eastern Time on Friday, September 30, … Continue reading "Artelo Biosciences to Present at the 2022 Ladenburg Thalmann Healthcare Conference on September 29th"\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/artelo-biosciences-to-present-at-the-2022-ladenburg-thalmann-healthcare-conference-on-september-29th\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2022-09-22T13:05:08+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODY1MTAxOCM1MTY1MzE3IzIxODc1NzA=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/artelo-biosciences-to-present-at-the-2022-ladenburg-thalmann-healthcare-conference-on-september-29th\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/artelo-biosciences-to-present-at-the-2022-ladenburg-thalmann-healthcare-conference-on-september-29th\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Artelo Biosciences to Present at the 2022 Ladenburg Thalmann Healthcare Conference on September 29th\",\"datePublished\":\"2022-09-22T13:05:08+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/artelo-biosciences-to-present-at-the-2022-ladenburg-thalmann-healthcare-conference-on-september-29th\\\/\"},\"wordCount\":505,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/artelo-biosciences-to-present-at-the-2022-ladenburg-thalmann-healthcare-conference-on-september-29th\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODY1MTAxOCM1MTY1MzE3IzIxODc1NzA=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/artelo-biosciences-to-present-at-the-2022-ladenburg-thalmann-healthcare-conference-on-september-29th\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/artelo-biosciences-to-present-at-the-2022-ladenburg-thalmann-healthcare-conference-on-september-29th\\\/\",\"name\":\"Artelo Biosciences to Present at the 2022 Ladenburg Thalmann Healthcare Conference on September 29th - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/artelo-biosciences-to-present-at-the-2022-ladenburg-thalmann-healthcare-conference-on-september-29th\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/artelo-biosciences-to-present-at-the-2022-ladenburg-thalmann-healthcare-conference-on-september-29th\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODY1MTAxOCM1MTY1MzE3IzIxODc1NzA=\",\"datePublished\":\"2022-09-22T13:05:08+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/artelo-biosciences-to-present-at-the-2022-ladenburg-thalmann-healthcare-conference-on-september-29th\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/artelo-biosciences-to-present-at-the-2022-ladenburg-thalmann-healthcare-conference-on-september-29th\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/artelo-biosciences-to-present-at-the-2022-ladenburg-thalmann-healthcare-conference-on-september-29th\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODY1MTAxOCM1MTY1MzE3IzIxODc1NzA=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODY1MTAxOCM1MTY1MzE3IzIxODc1NzA=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/artelo-biosciences-to-present-at-the-2022-ladenburg-thalmann-healthcare-conference-on-september-29th\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Artelo Biosciences to Present at the 2022 Ladenburg Thalmann Healthcare Conference on September 29th\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Artelo Biosciences to Present at the 2022 Ladenburg Thalmann Healthcare Conference on September 29th - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/artelo-biosciences-to-present-at-the-2022-ladenburg-thalmann-healthcare-conference-on-september-29th\/","og_locale":"en_US","og_type":"article","og_title":"Artelo Biosciences to Present at the 2022 Ladenburg Thalmann Healthcare Conference on September 29th - Market Newsdesk","og_description":"SOLANA BEACH, Calif., Sept. 22, 2022 (GLOBE NEWSWIRE) — Artelo Biosciences, Inc.\u00a0(Nasdaq:\u00a0ARTL), a clinical-stage pharmaceutical company focused on modulating lipid-signaling pathways to develop treatments for people living with cancer, pain, and neurological conditions, today announced that it will be presenting at the 2022 Ladenburg Thalmann Healthcare Conference being held on September 29, 2022 at the Sofitel Hotel in New York City. Gregory D. Gorgas, Chief Executive Officer of Artelo, is scheduled to present on Thursday, September 29th at 8:30 a.m. Eastern Time., with one-on-one meetings to be held throughout the conference. The webcast of the Company\u2019s presentation can also be accessed\u00a0here\u00a0and on the investor relations section of Artelo’s website at\u00a0https:\/\/ir.artelobio.com\/ as of 7:00 a.m. Eastern Time on Friday, September 30, … Continue reading \"Artelo Biosciences to Present at the 2022 Ladenburg Thalmann Healthcare Conference on September 29th\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/artelo-biosciences-to-present-at-the-2022-ladenburg-thalmann-healthcare-conference-on-september-29th\/","og_site_name":"Market Newsdesk","article_published_time":"2022-09-22T13:05:08+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODY1MTAxOCM1MTY1MzE3IzIxODc1NzA=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/artelo-biosciences-to-present-at-the-2022-ladenburg-thalmann-healthcare-conference-on-september-29th\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/artelo-biosciences-to-present-at-the-2022-ladenburg-thalmann-healthcare-conference-on-september-29th\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Artelo Biosciences to Present at the 2022 Ladenburg Thalmann Healthcare Conference on September 29th","datePublished":"2022-09-22T13:05:08+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/artelo-biosciences-to-present-at-the-2022-ladenburg-thalmann-healthcare-conference-on-september-29th\/"},"wordCount":505,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/artelo-biosciences-to-present-at-the-2022-ladenburg-thalmann-healthcare-conference-on-september-29th\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODY1MTAxOCM1MTY1MzE3IzIxODc1NzA=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/artelo-biosciences-to-present-at-the-2022-ladenburg-thalmann-healthcare-conference-on-september-29th\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/artelo-biosciences-to-present-at-the-2022-ladenburg-thalmann-healthcare-conference-on-september-29th\/","name":"Artelo Biosciences to Present at the 2022 Ladenburg Thalmann Healthcare Conference on September 29th - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/artelo-biosciences-to-present-at-the-2022-ladenburg-thalmann-healthcare-conference-on-september-29th\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/artelo-biosciences-to-present-at-the-2022-ladenburg-thalmann-healthcare-conference-on-september-29th\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODY1MTAxOCM1MTY1MzE3IzIxODc1NzA=","datePublished":"2022-09-22T13:05:08+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/artelo-biosciences-to-present-at-the-2022-ladenburg-thalmann-healthcare-conference-on-september-29th\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/artelo-biosciences-to-present-at-the-2022-ladenburg-thalmann-healthcare-conference-on-september-29th\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/artelo-biosciences-to-present-at-the-2022-ladenburg-thalmann-healthcare-conference-on-september-29th\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODY1MTAxOCM1MTY1MzE3IzIxODc1NzA=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODY1MTAxOCM1MTY1MzE3IzIxODc1NzA="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/artelo-biosciences-to-present-at-the-2022-ladenburg-thalmann-healthcare-conference-on-september-29th\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Artelo Biosciences to Present at the 2022 Ladenburg Thalmann Healthcare Conference on September 29th"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/688074","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=688074"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/688074\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=688074"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=688074"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=688074"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}